Step-by-step BAC water + syringe math for the three retatrutide vial sizes most vendors stock. Built around the TRIUMPH-4 dose titration. Research only, not human-use guidance.
Retatrutide reconstitution: divide the vial's labeled mg by the mL of bacteriostatic water added to get mg/mL concentration. For a 10 mg vial reconstituted with 2 mL BAC water, concentration is 5 mg/mL. To deliver a 2 mg titration dose, draw 0.4 mL = 40 units on a U-100 insulin syringe. Refrigerate at 2-8°C, protect from light, use within 14-30 days.
Reconstituting a retatrutide vial uses the same kit as any lyophilized peptide. The component list, in research-protocol terms:
The general mechanics of dissolving a lyophilized peptide are covered in the peptide reconstitution guide. This article is the retatrutide-specific math for the three vial sizes you actually see in vendor catalogs.
Reconstitution math is one division and one multiplication:
A worked example for a 10 mg retatrutide vial reconstituted with 2 mL of BAC water:
That's the whole calculation. Every example below is the same two operations with different inputs.
The three vial sizes most vendors stock for retatrutide are 5 mg, 10 mg, and 20 mg. The table below shows the mg/mL concentration each yields at the three common BAC water volumes, and what a 2 mg, 4 mg, 8 mg, and 12 mg dose looks like on a U-100 insulin syringe at each concentration.
| Vial | BAC water | Concentration | 2 mg dose | 4 mg dose | 8 mg dose | 12 mg dose |
|---|---|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 40 units | 80 units | n/a (would need 2 draws) | n/a |
| 5 mg | 2 mL | 2.5 mg/mL | 80 units | n/a (>100u) | n/a | n/a |
| 10 mg | 1 mL | 10 mg/mL | 20 units | 40 units | 80 units | n/a (>100u) |
| 10 mg | 2 mL | 5 mg/mL | 40 units | 80 units | n/a | n/a |
| 10 mg | 3 mL | 3.33 mg/mL | 60 units | n/a | n/a | n/a |
| 20 mg | 2 mL | 10 mg/mL | 20 units | 40 units | 80 units | n/a |
| 20 mg | 3 mL | 6.67 mg/mL | 30 units | 60 units | n/a | n/a |
| 20 mg | 4 mL | 5 mg/mL | 40 units | 80 units | n/a | n/a |
The pattern: a U-100 syringe holds 100 units (1 mL), so any dose that crosses that line either requires two draws or a more concentrated reconstitution. For the 8 mg and 12 mg TRIUMPH-4 maintenance arms, the 10 mg vial at 1 mL of BAC water (concentration 10 mg/mL) is the cleanest single-draw setup.
The published TRIUMPH Phase 3 titration steps from 2 mg to 12 mg in four-week increments (covered in detail in retatrutide dosing protocols). Using a 10 mg vial reconstituted with 1 mL of BAC water (concentration 10 mg/mL):
The 10 mg/mL concentration is the most syringe-friendly across the full titration. Lower concentrations push the 8 mg and 12 mg doses past the 100-unit syringe ceiling.
If you are working from a 5 mg vial, the titration stair-steps faster across vials: a single 5 mg vial covers two and a half weeks at 2 mg, or just over one week at 4 mg. The 5 mg vial is more economical for the lower titration steps but inefficient at maintenance dose. Most research-protocol buyers stocking past Week 8 move to the 10 mg or 20 mg vial.
The most-cited Reddit thread on this is "Reta Gone Cloudy After 2 Days in fridge" in r/Peptides (55 comments). The thread surfaces three real causes, in order of frequency:
Under-mixed peptide. Retatrutide is a 39-amino-acid sequence and takes longer to fully dissolve than a short peptide like BPC-157. The recommended approach is gentle swirling (not shaking) immediately after adding BAC water, followed by 10-15 minutes at room temperature before refrigeration. Cloudiness on Day 1 or Day 2 is often residual undissolved powder that clears with another gentle swirl.
Temperature shock. Adding cold BAC water (straight from the fridge) to room-temperature lyophilized powder can cause localized precipitation. Best practice is to let the BAC water reach room temperature before reconstitution.
Agitation precipitation. Shaking the vial — as opposed to swirling — physically denatures the peptide and produces persistent cloudiness that does not clear. A vial that was shaken vigorously and stayed cloudy should be discarded, not used.
A general rule from the literature on injectable peptide stability: a clear-then-cloudy vial that does not clear on gentle swirling at room temperature has likely degraded and should be discarded. Particles, color change, or visible flocculation are firm discard signals.
The post-reconstitution stability window for retatrutide tracks the GLP-1 / GIP / glucagon co-agonist class: 28-30 days at 2-8 degrees Celsius, protected from light, in the original glass vial. The benzyl alcohol in bacteriostatic water is the preservative that supports this multi-day window.
For longer storage, the protocol is to aliquot the reconstituted vial into single-dose syringes or small sterile vials, freeze at -20 degrees Celsius, and thaw each aliquot just before use. The cost is one freeze-thaw cycle per aliquot. The peptide-stability literature consistently shows freeze-thaw cycles as the dominant degradation pathway, so this approach trades a single thaw event per dose for indefinite frozen shelf life.
Do not freeze the parent vial and re-freeze. Aliquot first, freeze the aliquots.
The volume is a choice, not a fixed number. Most research protocols add 1 mL, 2 mL, or 3 mL of bacteriostatic water depending on how readable the resulting concentration is on a U-100 insulin syringe. For a 10 mg retatrutide vial, 2 mL of BAC water yields 5 mg/mL, which makes a 2 mg dose equal to 40 units on the syringe — a round number that is easy to draw without misreading the gradations.
Standard U-100 insulin syringes (27-31 gauge, 0.5 inch needle) are the typical research-protocol choice for any GLP-1-class peptide, including retatrutide. Each unit on the U-100 scale equals 0.01 mL, which makes the dose math straightforward. For draws above 0.6 mL, a 1 mL tuberculin syringe with mL gradations is more readable than counting 60 plus units.
Reconstituted retatrutide is generally documented as stable for 28-30 days at refrigerator temperature (2-8°C) when protected from light, consistent with the stability window for the GLP-1 / GIP / glucagon co-agonist class. Longer storage requires freezing single-dose aliquots and accepting one freeze-thaw cycle per aliquot. The 28-30 day window comes from analog-class manufacturer stability data, not retatrutide-specific published trials.
Cloudiness in a reconstituted retatrutide vial is usually one of three things: under-mixed peptide that has not fully dissolved (swirl gently, do not shake, give it 10-15 minutes), bacteriostatic water that was too cold relative to the lyophilized powder, or precipitation from agitation. The r/Peptides thread "Reta Gone Cloudy After 2 Days in fridge" (55 comments) documents the pattern: most cloudiness resolves on gentle swirling. Persistent cloudiness, particles, or a visible color change suggests the vial should be discarded.
Splitting is the entire point of reconstitution math. Once the vial is reconstituted to a known mg/mL concentration, each dose is just a fraction of the total volume. A 10 mg vial reconstituted with 2 mL of BAC water gives five 2 mg doses at 0.4 mL each, or two and a half 4 mg doses at 0.8 mL each. The vial stores in the fridge for the full stability window; you draw each dose fresh.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.